Manni Mohyuddin: Vague enrollment criteria in smoldering myeloma trials opens door to harm/over-interventionalism

Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on X/Twitter:

“Vague enrollment criteria in smoldering myeloma trials opens door to harm/over-interventionalism. The median plasma cell percentage was only 20%, and the most common high-risk abnormality was gain1q.

Many of these patients would have stayed stable off therapy for years.”

Source: Manni Mohyuddin/X